FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely paediatric resuscitation, and may be used for treating depressed cases in newborns with a surgical pathology. That is ensured by intravenous administration of 20% neat human serum albumin 3-5 ml/kg (no more than 1 g/kg) a day for 10 minutes. Observing persistent arterial hypertension requires an additional intravenous infusion of normal saline 3 ml/kg for 15 minutes, while in the presence of recurrent persistent arterial hypertension, 6% hydroxyethyl starch 3 ml/kg for 30 minutes is administered intravenously.
EFFECT: method enables a higher effect of the performed anti-shock therapy combined with reduced postoperative complications ensured by the prevented liquid outflow from the blood flow that might happen due to high oncotic and osmotic pressure of the concentrated solution of human albumin with contracting the infusion therapy extent.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CONDUCTING LOW-OPIOID ANESTHESIA IN PATIENTS WITH MORBID OBESITY | 2017 |
|
RU2649454C1 |
METHOD OF INFUSION SUPPORT FOR CAESAREAN SECTION UNDER SPINAL ANAESTHESIA | 2015 |
|
RU2600668C1 |
METHOD FOR REPLACEMENT OF MASSIVE PERIOPERATIVE BLOOD LOSS | 2009 |
|
RU2409395C1 |
METHOD FOR PREVENTION OF SEVERE COMPLICATIONS ACCOMPANYING SURGICAL MANAGEMENT OF MASSIVE AND SUBMASSIVE BLOOD LOSS WITH CONTINUOUS HAEMORRHAGES | 2011 |
|
RU2475234C2 |
METHOD OF TREATMENT OF UNCONTROLLED HEMODYNAMICS OF PATIENTS ILL WITH CHROMAFFINOMAS | 0 |
|
SU1386200A1 |
METHOD FOR PREVENTING ACUTE HEPATIC FAILURE AFTER HEMIHEPATECTOMY | 2000 |
|
RU2204393C2 |
METHOD FOR INFUSION THERAPY IN KETOACIDOGENIC COMA IN PATIENT WITH DIABETES MELLITUS | 2003 |
|
RU2242236C1 |
METHOD FOR INTRAOPERATIVE PROPHYLACTIC TREATMENT OF ISCHEMIC DAMAGE TO PANCREAS AND LIVER IN CASE OF COMBINED SHOCK-PRODUCING INJURY | 2016 |
|
RU2620496C1 |
METHOD OF ANAESTHESIA CARE OF OPERATIVE DELIVERY IN WOMEN WITH SEVERE GESTOSIS | 2010 |
|
RU2436603C1 |
METHOD OF PREVENTING ENDOTHELIAL DAMAGE IN CRITICALLY ILL PATIENTS | 2023 |
|
RU2812594C1 |
Authors
Dates
2013-08-27—Published
2010-11-19—Filed